Research programme: neurological disorders therapeutics - PrevacusAlternative Names: PRV-002; Synthetic neurosteroids - Prevacus
Latest Information Update: 13 Jan 2015
At a glance
- Originator Prevacus
- Class Steroids
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Brain injuries; Neurological disorders
Most Recent Events
- 09 Jan 2015 Preclinical trials in Neurological disorders in USA (Intranasal) prior to January 2015
- 09 Jan 2015 Preclinical trials in Brain injuries in USA (Intranasal) prior to January 2015